Skip to content

Clinical trials

Phase 4 Major Depressive Disorder trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 4 Country / region: Canada Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20052
20073
20081
20093
20113
20121
20141
20152
20162
20171
20192
20213
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status5
Recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nova Scotia Health Authority3
Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal2
Dr Alexander McIntyre Inc.2
Hamilton Health Sciences Corporation2
Unity Health Toronto2
University of Calgary2
Assurex Health Inc.1
Brainsway1
Centre for Addiction and Mental Health1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder27
Depressive Disorder, Treatment-Resistant4
Anxiety Disorders2
Agoraphobia1
Bipolar Disorder1
Cognitive Dysfunction1
Dementia1
Depressive Disorder1
Dysthymic Disorder1
Hot Flashes1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.